down arrow

Hisamitsu Pharmaceutical Co., Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3784600003
JPY
4,145.00
-75 (-1.78%)

Dec 11

TKS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
May'25
Feb'25
Nov'24
Aug'24
May'24
Feb'24
Nov'23
Net Sales
34,665.00
44,753.00
35,797.00
39,646.00
35,810.00
38,879.00
35,850.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
34,665.00
44,753.00
35,797.00
39,646.00
35,810.00
38,879.00
35,850.00
Raw Material Cost
13,379.00
19,945.00
13,818.00
16,042.00
15,005.00
18,508.00
15,897.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.00
8.00
0.00
12.00
4.00
6.00
5.00
Selling and Distribution Expenses
17,920.00
19,133.00
17,765.00
15,995.00
14,301.00
16,901.00
14,178.00
Other Expenses
-0.20
-0.80
0.00
274.00
235.00
256.60
189.70
Total Expenditure (Excl Depreciation)
31,299.00
39,078.00
31,583.00
34,789.00
31,660.00
37,981.00
31,977.00
Operating Profit (PBDIT) excl Other Income
3366
5675
4214
4857
4150
898
3873
Other Income
429.00
3,952.00
2,092.00
1,343.00
2,770.00
2,480.00
1,148.00
Operating Profit (PBDIT)
5,485.00
11,457.00
7,822.00
7,776.00
8,333.00
4,832.00
6,188.00
Interest
2.00
8.00
0.00
12.00
4.00
6.00
5.00
Exceptional Items
0.00
-343.00
0.00
0.00
0.00
-847.00
0.00
Gross Profit (PBDT)
21,286.00
24,808.00
21,979.00
23,604.00
20,805.00
20,371.00
19,953.00
Depreciation
1,690.00
1,830.00
1,516.00
1,576.00
1,413.00
1,454.00
1,167.00
Profit Before Tax
3,791.00
9,275.00
6,311.00
6,186.00
6,915.00
2,527.00
5,021.00
Tax
1,154.00
1,035.00
1,650.00
1,756.00
1,944.00
575.00
1,212.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,564.00
8,098.00
4,562.00
4,309.00
4,789.00
1,860.00
3,692.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,564.00
8,098.00
4,562.00
4,309.00
4,789.00
1,860.00
3,692.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
73.00
142.00
98.00
121.00
182.00
91.00
117.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,637.00
8,240.00
4,660.00
4,430.00
4,971.00
1,951.00
3,809.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,70,376.00
2,76,826.00
2,59,891.00
2,73,575.00
2,64,580.00
2,64,877.00
2,69,086.00
Earnings per share (EPS)
35.1
110.39
62.21
58.74
63.81
24.54
48.42
Diluted Earnings per share
35.1
110.39
62.21
58.74
63.81
24.54
48.42
Operating Profit Margin (Excl OI)
9.71%
12.68%
11.77%
12.25%
11.59%
2.31%
10.8%
Gross Profit Margin
15.81%
24.81%
21.86%
19.58%
23.26%
10.24%
17.26%
PAT Margin
7.4%
18.09%
12.74%
10.87%
13.37%
4.78%
10.3%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended May 2025 is -3.20% vs 11.57% in May 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended May 2025 is -46.95% vs 18.95% in May 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended May 2025 is -9.11% vs 0.94% in May 2024

stock-summary

Interest

YoY Growth in quarter ended May 2025 is -50.00% vs 0.00% in May 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended May 2025 has fallen from May 2024

Compare Quarterly Results Of Hisamitsu Pharmaceutical Co., Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
34,665.00
68,737.00
-34,072.00
-49.57%
Other Operating Income
0.00
0.00
0.00
Total Operating income
34,665.00
68,737.00
-34,072.00
-49.57%
Raw Material Cost
13,379.00
33,795.00
-20,416.00
-60.41%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.00
749.00
-747.00
-99.73%
Selling and Distribution Expenses
17,920.00
21,204.00
-3,284.00
-15.49%
Other Expenses
-0.20
545.80
-546.00
-100.04%
Total Expenditure (Excl Depreciation)
31,299.00
61,206.00
-29,907.00
-48.86%
Operating Profit (PBDIT) excl Other Income
3,366.00
7,531.00
-4,165.00
-55.30%
Other Income
429.00
669.00
-240.00
-35.87%
Operating Profit (PBDIT)
5,485.00
12,697.00
-7,212.00
-56.80%
Interest
2.00
749.00
-747.00
-99.73%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
21,286.00
34,942.00
-13,656.00
-39.08%
Depreciation
1,690.00
4,497.00
-2,807.00
-62.42%
Profit Before Tax
3,791.00
7,450.00
-3,659.00
-49.11%
Tax
1,154.00
1,587.00
-433.00
-27.28%
Provisions and contingencies
0
0
0.00
Profit After Tax
2,564.00
5,878.00
-3,314.00
-56.38%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,564.00
5,878.00
-3,314.00
-56.38%
Share in Profit of Associates
0
0
0.00
Minority Interest
73.00
-15.00
88.00
586.67%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,637.00
5,863.00
-3,226.00
-55.02%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,70,376.00
2,81,265.00
-10,889.00
-3.87%
Earnings per share (EPS)
35.10
17.28
17.82
103.12%
Diluted Earnings per share
35.10
17.28
17.82
103.12%
Operating Profit Margin (Excl OI)
9.71%
10.96%
0.00
-1.25%
Gross Profit Margin
15.81%
17.38%
0.00
-1.57%
PAT Margin
7.40%
8.55%
0.00
-1.15%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3,466.50 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is -3.16%

stock-summary

YoY Growth in quarter ended May 2025 is -3.20% vs 11.57% in May 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 263.70 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is -43.41%

stock-summary

YoY Growth in quarter ended May 2025 is -46.95% vs 18.95% in May 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 505.60 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is -11.76%

stock-summary

YoY Growth in quarter ended May 2025 is -9.11% vs 0.94% in May 2024

Quarterly - Interest
Interest 0.20 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is 0.00%

stock-summary

YoY Growth in quarter ended May 2025 is -50.00% vs 0.00% in May 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.71%
in May 2025

Figures in %
stock-summary

QoQ Growth in quarter ended May 2025 has fallen from Nov 2024

stock-summary

YoY Growth in quarter ended May 2025 has fallen from May 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."